Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Adolor studies opioid antagonists for treatment of opiate-induced constipation

Dec. 3, 1999

New 5-HT4 ligands from Kyowa Hakko useful for GI motility disorders

Dec. 2, 1999

NMDA antagonists reported to be useful for IBS

Dec. 1, 1999

DWH-146e and rolipram synergistically block inflammation in murine model of peritonitis

Nov. 30, 1999

Eradication of H. pylori infection obtained with low doses of new cephem

Nov. 26, 1999

Korean investigators disclose new hepatoprotective agents

Nov. 26, 1999

InKine seeks FDA approval of Diacol

Nov. 24, 1999

Agents for ulcers and other GI disorders under study at AstraZeneca

Nov. 24, 1999

PEG-Intron submitted for marketing approval in Europe

Nov. 22, 1999

XTL and Roche to evaluate HCV therapeutics

Nov. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...